International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersAngela Dispenzieri, Sagar Lonial, Meletios Α. Dimopoulos et al.|Leukemia|2008Cited by 808
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to ProgressionRobert Z. Orlowski, Jean‐Luc Harousseau|Journal of Clinical Oncology|2007Cited by 645
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working GroupMeletios Α. Dimopoulos, Jesús F. San Miguel, Evangelos Terpos et al.|Journal of Clinical Oncology|2010Cited by 409
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Jean‐Luc Harousseau, Shaji Kumar et al.|The Lancet Oncology|2021Cited by 266
Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCelso Arrais‐Rodrigues, Vanderson Rocha, Guillermo Sanz et al.|Journal of Clinical Oncology|2008Cited by 202